Life Science Software Market Report and Forecast 2025-2034
Description
The global life science software market reached a value of approximately USD 16.75 Billion in 2024. The market is projected to grow at a CAGR of 10.90 % between 2025 and 2034, reaching a value of around USD 47.13 Billion by 2034.
Life Science Software Market Growth
The life science software market is propelled by the shift towards personalized medicine which requires advanced software for genetic analysis, biomarker discovery, and patient stratification. These tools help in tailoring treatments to individual patients based on their genetic profiles.
Automation technologies, including robotic process automation (RPA) and laboratory automation, are enhancing efficiency in R&D and manufacturing processes.
In the U.S., in the fiscal year 2022, academic institutions spent a total of USD 97.8 billion on research and development, marking a USD 8.0 billion increase compared to FY 2021.
Key Trends and Developments
Artificial intelligence and machine learning, cloud computing, big data analytics, and regulatory compliance automation are the major trends impacting global life science software market growth.
June 2024
Sware has secured $6 million in a Series B funding round to expedite innovation in life sciences by automating the software validation required by the US Food and Drug Administration.
June 2024
SCIEX, a leader in life science analytical technologies, partnered with Mass Analytica to launch AI quant software. Using AI and machine learning, it rapidly processes data and generates insights, saving time and boosting productivity.
March 2024
NVIDIA has introduced over two dozen new microservices, enabling healthcare enterprises globally to utilise the latest advancements in generative AI from any location and cloud platform.
December 2023
Biosero, specialised in laboratory automation solutions, has signed a $28 million agreement with a global life science company. The project involves designing and building an automated R&D platform across five sub-projects, including hardware and software.
Artificial Intelligence and Machine Learning
AI and ML are revolutionising data analysis and drug discovery by automating tasks, analysing large datasets, and enabling faster, more accurate predictions and insights.
Cloud Computing
Cloud-based solutions allow life science companies to store and manage vast amounts of data securely, collaborate across geographies, and access powerful computational resources on demand.
Big Data Analytics
Analysing large datasets is crucial for genomics, clinical trials, and personalised medicine. Advanced analytics tools enhance understanding of disease mechanisms, and patient responses, and optimise clinical trial designs.
Regulatory Compliance Automation
Software that ensures compliance with FDA and EMA standards is in high demand, helping to maintain data integrity, audit readiness, and regulatory adherence, thereby reducing the risk of non-compliance.
Life Science Software Market Trends
The rising demand for life science software is driven by innovations in imaging technologies and diagnostic software, which improve the speed and accuracy of disease diagnosis, leveraging AI for enhanced image analysis.
Moreover, automation technologies such as robotic process automation (RPA) and laboratory automation enhance efficiency in research and manufacturing by reducing errors, increasing productivity, and enabling precise tasks.
Life Science Software Industry Segmentation
Life Science Software Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Component
Software components enhance the life science software market by enabling sophisticated data analysis, allowing researchers to derive meaningful insights from complex datasets more efficiently.
Software components facilitate the adoption of emerging technologies such as artificial intelligence, machine learning, and cloud computing, which further drive innovation and growth in the life sciences sector.
Service providers offer consulting services to help life science companies implement and optimize software solutions tailored to their specific needs, driving adoption and utilisation.
Cloud-based deployment contributes to the life science software market growth by facilitating data integration and interoperability by providing APIs and standardised protocols for accessing and sharing data across different systems and applications.
Leading cloud service providers offer robust security measures and compliance certifications, ensuring the protection of sensitive data under industry regulations such as HIPAA and GDPR.
On-premises deployment assures organisations that their data remains within their physical control and jurisdiction, mitigating concerns related to data sovereignty and geopolitical risks associated with storing data in third-party cloud environments.
Leading Manufacturers in the Life Science Software Market
The companies are providers of healthcare solutions, services, and products such as asset management, AI, machine learning, and others.
CPSI
Founded in 1979 and is headquartered in the United States. CPSI is a top provider of healthcare solutions and services designed for community hospitals, clinics, and post-acute care facilities.
SAP SE
Established in 1972 and is headquartered in Walldorf, BW. The company offers various products under segments including based on industry, category, business technology platform, business transformation management, and featured.
Autodesk Inc.
Founded in 1982 and is headquartered in San Francisco, CA. The company's technology spans architecture, engineering, construction, product design, manufacturing, and media and entertainment.
International Business Machines Corp
Established in 1911 and is headquartered in Armonk, New York. The company offers various products including AI and machine learning, asset management, analytics, business automation, and other products.
Other global life science software market key players are Medidata Solutions, Inc., Veeva Systems, PAREXEL International Corporation, QuintilesIMS Incorporated, Optum Inc., Cerner Corporation, and Cognizant, among others.
Life Science Software Market Analysis by Region
During the forecast period, North America is poised to lead, driven by abundant market opportunities and the presence of key players. The region's market growth is further expected to be propelled by the demand for patient data security, convenient data access, and efficient data management.
According to GOI, the Ministry of Chemicals & Fertilizers Department of Pharmaceuticals, in the fiscal year 2021-22, the total annual turnover of Pharmaceuticals was USD 46,457 million whereas in 2020-2021 it was USD 44,287 million. This indicates the rise in the demand for life science software market in India.
According to the National Science Board, The U.S. research and experimental development (R&D) performance reached USD 667 billion in 2019 and an estimated USD 708 billion in 2020. This increase in the R&D performance has resulted in rising demand for the life science software market in the country.
Life Science Software Market Report Snapshots
Life Science Software Market Size
Life Science Software Market Growth
Life Science Software Market Trends
Life Science Software Market Share
Life Science Software Manufacturers
Life Science Software Market Regional Analysis
Life Science Software Market Growth
The life science software market is propelled by the shift towards personalized medicine which requires advanced software for genetic analysis, biomarker discovery, and patient stratification. These tools help in tailoring treatments to individual patients based on their genetic profiles.
Automation technologies, including robotic process automation (RPA) and laboratory automation, are enhancing efficiency in R&D and manufacturing processes.
In the U.S., in the fiscal year 2022, academic institutions spent a total of USD 97.8 billion on research and development, marking a USD 8.0 billion increase compared to FY 2021.
Key Trends and Developments
Artificial intelligence and machine learning, cloud computing, big data analytics, and regulatory compliance automation are the major trends impacting global life science software market growth.
June 2024
Sware has secured $6 million in a Series B funding round to expedite innovation in life sciences by automating the software validation required by the US Food and Drug Administration.
June 2024
SCIEX, a leader in life science analytical technologies, partnered with Mass Analytica to launch AI quant software. Using AI and machine learning, it rapidly processes data and generates insights, saving time and boosting productivity.
March 2024
NVIDIA has introduced over two dozen new microservices, enabling healthcare enterprises globally to utilise the latest advancements in generative AI from any location and cloud platform.
December 2023
Biosero, specialised in laboratory automation solutions, has signed a $28 million agreement with a global life science company. The project involves designing and building an automated R&D platform across five sub-projects, including hardware and software.
Artificial Intelligence and Machine Learning
AI and ML are revolutionising data analysis and drug discovery by automating tasks, analysing large datasets, and enabling faster, more accurate predictions and insights.
Cloud Computing
Cloud-based solutions allow life science companies to store and manage vast amounts of data securely, collaborate across geographies, and access powerful computational resources on demand.
Big Data Analytics
Analysing large datasets is crucial for genomics, clinical trials, and personalised medicine. Advanced analytics tools enhance understanding of disease mechanisms, and patient responses, and optimise clinical trial designs.
Regulatory Compliance Automation
Software that ensures compliance with FDA and EMA standards is in high demand, helping to maintain data integrity, audit readiness, and regulatory adherence, thereby reducing the risk of non-compliance.
Life Science Software Market Trends
The rising demand for life science software is driven by innovations in imaging technologies and diagnostic software, which improve the speed and accuracy of disease diagnosis, leveraging AI for enhanced image analysis.
Moreover, automation technologies such as robotic process automation (RPA) and laboratory automation enhance efficiency in research and manufacturing by reducing errors, increasing productivity, and enabling precise tasks.
Life Science Software Industry Segmentation
Life Science Software Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Component
- Software
- Service
- Cloud-based
- On-premises
- Research and Development
- Clinical Trials
- Drug Safety
- Regulatory Compliance
- Supply Chain Management
- Others
- Pharmaceuticals
- Biotechnology
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Software components enhance the life science software market by enabling sophisticated data analysis, allowing researchers to derive meaningful insights from complex datasets more efficiently.
Software components facilitate the adoption of emerging technologies such as artificial intelligence, machine learning, and cloud computing, which further drive innovation and growth in the life sciences sector.
Service providers offer consulting services to help life science companies implement and optimize software solutions tailored to their specific needs, driving adoption and utilisation.
Cloud-based deployment contributes to the life science software market growth by facilitating data integration and interoperability by providing APIs and standardised protocols for accessing and sharing data across different systems and applications.
Leading cloud service providers offer robust security measures and compliance certifications, ensuring the protection of sensitive data under industry regulations such as HIPAA and GDPR.
On-premises deployment assures organisations that their data remains within their physical control and jurisdiction, mitigating concerns related to data sovereignty and geopolitical risks associated with storing data in third-party cloud environments.
Leading Manufacturers in the Life Science Software Market
The companies are providers of healthcare solutions, services, and products such as asset management, AI, machine learning, and others.
CPSI
Founded in 1979 and is headquartered in the United States. CPSI is a top provider of healthcare solutions and services designed for community hospitals, clinics, and post-acute care facilities.
SAP SE
Established in 1972 and is headquartered in Walldorf, BW. The company offers various products under segments including based on industry, category, business technology platform, business transformation management, and featured.
Autodesk Inc.
Founded in 1982 and is headquartered in San Francisco, CA. The company's technology spans architecture, engineering, construction, product design, manufacturing, and media and entertainment.
International Business Machines Corp
Established in 1911 and is headquartered in Armonk, New York. The company offers various products including AI and machine learning, asset management, analytics, business automation, and other products.
Other global life science software market key players are Medidata Solutions, Inc., Veeva Systems, PAREXEL International Corporation, QuintilesIMS Incorporated, Optum Inc., Cerner Corporation, and Cognizant, among others.
Life Science Software Market Analysis by Region
During the forecast period, North America is poised to lead, driven by abundant market opportunities and the presence of key players. The region's market growth is further expected to be propelled by the demand for patient data security, convenient data access, and efficient data management.
According to GOI, the Ministry of Chemicals & Fertilizers Department of Pharmaceuticals, in the fiscal year 2021-22, the total annual turnover of Pharmaceuticals was USD 46,457 million whereas in 2020-2021 it was USD 44,287 million. This indicates the rise in the demand for life science software market in India.
According to the National Science Board, The U.S. research and experimental development (R&D) performance reached USD 667 billion in 2019 and an estimated USD 708 billion in 2020. This increase in the R&D performance has resulted in rising demand for the life science software market in the country.
Life Science Software Market Report Snapshots
Life Science Software Market Size
Life Science Software Market Growth
Life Science Software Market Trends
Life Science Software Market Share
Life Science Software Manufacturers
Life Science Software Market Regional Analysis
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Life Science Software Market Overview
- 3.1 Global Life Science Software Market Historical Value (2018-2024)
- 3.2 Global Life Science Software Market Forecast Value (2025-2034)
- 4 Global Life Science Software Market Landscape
- 4.1 Global Life Science Software Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Life Science Software Product Landscape
- 4.2.1 Analysis by Component
- 4.2.2 Analysis by Deployment
- 4.2.3 Analysis by Application
- 5 Global Life Science Software Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Life Science Software Market Segmentation
- 6.1 Global Life Science Software Market by Component
- 6.1.1 Market Overview
- 6.1.2 Software
- 6.1.3 Service
- 6.2 Global Life Science Software Market by Deployment
- 6.2.1 Market Overview
- 6.2.2 Cloud-based
- 6.2.3 On-premises
- 6.3 Global Life Science Software Market by Application
- 6.3.1 Market Overview
- 6.3.2 Research and Development
- 6.3.3 Clinical Trials
- 6.3.4 Drug Safety
- 6.3.5 Regulatory Compliance
- 6.3.6 Supply Chain Management
- 6.3.7 Others
- 6.4 Global Life Science Software Market by End User
- 6.4.1 Market Overview
- 6.4.2 Pharmaceuticals
- 6.4.3 Biotechnology
- 6.4.4 Others
- 6.5 Global Life Science Software Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Life Science Software Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Life Science Software Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Life Science Software Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Life Science Software Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Life Science Software Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 CPSI
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Autodesk Inc.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 International Business Machines Corp
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 SAP SE
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Medidata Solutions, Inc
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Veeva Systems
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 PAREXEL International Corporation
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 QuintilesIMS Incorporated
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Optum Inc.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Cerner Corporation
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Cognizant
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 18 Global Life Science Software Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
